|
Current issue
Archive
About the journal
Editorial board
Reviewers
Abstracting and indexing
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
4/2022
vol. 7 Original paper
Conventional methods and natural therapeutic options in the treatment of onychomycosis
Faustyna Kuros
1
,
Dominika Wcisło-Dziadecka
2
Long-Term Care Nursing vol. 7, year 2022, issue 4, p. 57-68
Online publish date: 2023/02/28
Article file
- 6.pdf
[0.29 MB]
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
1. Baswan S, Kasting GB, Li SK, Wickett R, Adams B, Eurich S, Schamper R. Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases. Mycoses. 2017;60(5):284-295. 2.
Maatouk I, Haber R, Benmehidi N. Onychoscopic evaluation of distal and lateral subungual onychomycosis: A cross-sectional study in Lebanon. Curr Med Mycol. 2019;5(2):41-44. 3.
Piraccini BM, Iorizzo M, Lencastre A. Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer: A Review of Its Use in Onychomycosis. Dermatol Ther (Heidelb). 2020;10(5):917-929. 4.
Lim SS, Ohn J, Mun JH. Diagnosis of Onychomycosis: From Conventional Techniques and Dermoscopy to Artificial Intelligence. Front Med (Lausanne). 2021;15(8):637216. 5.
Hao X, Yim J, Freedman D, Siddiqui S, Levine D, Tritto M, Saffo GM, Isaac A, Mirkin G. PAS stain based histological classification and severity grading of toenail onychomycosis. Med Mycol. 2020;58(4):453-459. 6.
Abu El-Hamd M, Abd Elhameed MI, Shalaby MFM, Saleh R. In vitro antifungal susceptibility testing of fungi in patients with onychomycosis. Dermatol Ther. 2020;33(3):e13429. 7.
Hawks MK, Rupert JP, Svarverud JE. Terbinafine for Onychomycosis. Am Fam Physician. 2018;98(3):Online https://pubmed.ncbi.nlm.nih.gov/30215902/ 8.
Nargis T, Pinto M, Shenoy MM, Hegde S. Dermoscopic Features of Distal Lateral Subungual Onychomycosis. Indian Dermatol Online J. 2018;9(1):16-19. 9.
Kayarkatte MN, Singal A, Pandhi D, Das S, Sharma S. Nail dermoscopy (onychoscopy) findings in the diagnosis of primary onychomycosis: A cross-sectional study. Indian J Dermatol Venereol Leprol. 2020;86(4):341-349. 10.
Piraccini BM. Zmiany paznokciowe wywołane przez drobnoustroje. In: Maleszka R. Choroby paznokci praktyczny poradnik – diagnostyka i leczenie. Czelej. 2018:122-138. 11.
Maleszka R, Adamski Z, Szepietowski J, Baran E. Leczenie powierzchownych zakażeń grzybiczych - rekomendacje ekspertów Sekcji Mikologicznej Polskiego Towarzystwa Dermatologicznego. Przegl. Dermatol. 2015;102:305-315. 12.
Leung AKC, Lam JM, Leong KF, Hon KL, Barankin B, Leung AAM, Wong AHC. Onychomycosis: An Updated Review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32-45. 13.
Vanam HP, Rao PN, Mohanram K, Yegneswaran PP, Rudramurthy SPM. Distal Lateral Subungual Onychomycosis Owing to Tritirachium oryzae: A Bystander or Invader? Mycopathologia. 2018;183(2):459-463. 14.
Chetana K, Menon R, David BG. Onychoscopic evaluation of onychomycosis in a tertiary care teaching hospital: a cross-sectional study from South India. Int J Dermatol. 2018;57(7):837-842. 15.
Grover C, Jakhar D, Sharma S. The grid pattern of white superficial onychomycosis. Indian J Dermatol Venereol Leprol. 2020;86(5):568-570. 16.
Mehta M, Sharma J, Bhardwaj SB. Proximal subungual onychomycosis of digitus minimus due to Aspergillus brasiliensis. Pan Afr Med J. 2020;19;35:79. 17.
Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, Piraccini BM. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020 Sep; 34(9):1972-1990. 18.
Ricardo JW, Lipner SR. Safety of current therapies for onychomycosis. Expert Opin Drug Saf. 2020;19(11):1395-1408. 19.
Lipner SR, Scher RK. Onychomycosis: Treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853-867. 20.
Maxfield L, Preuss CV, Bermudez R. Terbinafine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2022; PMID: 31424802 Bookshelf ID: NBK545218. 21.
Dhamoon RK, Popli H, Gupta M. Novel Drug Delivery Strategies for the Treatment of Onychomycosis. Pharm Nanotechnol. 2019;7(1):24-38. 22.
Gupta AK, Mays RR, Versteeg SG. Shear NH, Piguet V. Update on current approaches to diagnosis and treatment of onychomycosis. Expert Rev Anti Infect Ther. 2018;16(12):929-938. 23.
Gupta AK, Venkataraman M, Renaud HJ, Summerbell R, Shear NH, Piguet V. A Paradigm Shift in the Treatment and Management of Onychomycosis. Skin Appendage Disord. 2021;7(5):351- 358. 24.
Ma W, Si C, Kasyanju Carrero LM, Liu HF, Yin XF, Liu J, Xu Y, Zhou B. Laser treatment for onychomycosis: A systematic review and meta-analysis. Medicine (Baltimore) 2019;98(48):e17948. 25.
Fernandez J, del Valle Ferna ́ndez I, Villar CJ, Lombo ́ F. Combined laser and ozone therapy for onychomycosis in an in vitro and ex vivo model. PLoS ONE 2021;16(6): e0253979. 26.
Roana J, Mandras N, Scalas D, Campagna P, Tullio V. Antifungal Activity of Melaleuca alternifolia Essential Oil (TTO) and Its Synergy with Itraconazole or Ketoconazole against Trichophyton rubrum. Molecules. 2021;26(2):461. 27.
Bseiso EA, Nasr M, Sammour OA, Abd El Gawad NA. Novel nail penetration enhancer containing vesicles “nPEVs” for treatment of onychomycosis. Drug Deliv. 2016;23(8):2813-2819. 28.
Abobakr FE, Fayez SM, Elwazzan VS, Sakran W. Effect of Different Nail Penetration Enhancers in Solid Lipid Nanoparticles Containing Terbinafine Hydrochloride for Treatment of Onychomycosis. AAPS PharmSciTech. 2021;22(1):33. 29.
Alqahtani A, Raut B, Khan S, Mohamed JMM, Fatease AA, Alqahtani T, Alamri A, Ahmad F, Krishnaraju V. The Unique Carboxymethyl Fenugreek Gum Gel Loaded Itraconazole Self-Emulsifying Nanovesicles for Topical Onychomycosis Treatment. Polymers (Basel). 2022;14(2):325. 30.
Kimura U, Suga Y. Laser Therapies for Onychomycosis in Japan. Med Mycol J. 2018;59(3):J45-J49. 31.
Chen B, Sun Y, Zhang J, Chen R, Zhong X, Wu X, Zheng L, Zhao J. In vitro Evaluation of Photodynamic Effects Against Biofilms of Dermatophytes Involved in Onychomycosis. Front Microbiol 2019;7(10):1228. 32.
Valkov A, Zinigrad M, Nisnevitch M. Photodynamic Eradication of Trichophyton rubrum and Candida albicans. Pathogens. 2021;10(3):263. 33.
Ma W, Zhang M, Cui Z, Wang X, Niu X, Zhu Y, Yao Z, Ye F, Geng S, Liu C. Aloe-emodin-mediated antimicrobial photodynamic therapy against dermatophytosis caused by Trichophyton rubrum. Microb Biotechnol. 2022;15(2):499-512. 34.
Nair AB, Al-Dhubiab BE, Shah J, Gorain B, Jacob S, Attimarad M, Sreeharsha N, Venugopala KN, Morsy MA. Constant Voltage Iontophoresis Technique to Deliver Terbinafine via Transungual Delivery System: Formulation Optimization Using Box-Behnken Design and In Vitro Evaluation. Pharmaceutics. 2021;13(10):1692. 35.
Glenc-Ambroży M, Piejko L. Rola olejków eterycznych w terapii grzybicy skóry i jej przydatków. Post Fitoter. 2020;21(4):236-240. 36.
Flores FC, Beck RC, da Silva Cde B. Essential Oils for Treatment for Onychomycosis: A Mini- Review. Mycopathologia. 2016;181(1-2):9-15. 37.
Król SK, Skalicka-Woźniak K, Kandefer-Szerszeń M, Stepulak A. Aktywność biologiczna i farmakologiczna olejków eterycznych w leczeniu i profilaktyce chorób infekcyjnych. Postepy Hig Med Dosw. 2013;67:1000-1007. 38.
Przetaczek-Rożnowska I, Warzecha G. Analiza znajomości i wykorzystania olejków eterycznych wśród wybranej grupy konsumentów. Med Rodz 2017;20(1):31-36. 39.
Wolski T, Najda A, Kędzia B, Wolska-Gawron K. Fitoterapia chorób dermatologicznych. Post Fitoter. 2017;18(4):298-308. 40.
Wyszkowska-Kolatko M, Koczurkiewicz P, Wójcik K, Pękala E. Rośliny lecznicze w terapii chorób skóry. Post Fitoter. 2015;16(3):184-192. 41.
Garbusińska A, Mertas A, Szliszka E, Król W. Aktywność przeciwdrobnoustrojowa olejku z drzewa herbacianego (Tea Tree Oil) w badaniach in vitro. Cz. II. Post Fitoter. 2011;3:175-184. 42.
Marcos-Tejedor F, González-García P, Mayordomo R. Solubilization in vitro of tea tree oil and first results of antifungal effect in onychomycosis. Enferm Infecc Microbiol Clin (Engl Ed). 2021;39(8):395-398. 43.
Kraśniewska K, Gniewosz M, Kosakowska O, Pobiega K. Ocena składu chemicznego oraz właściwości przeciwdrobnoustrojowych olejku eterycznego z lawendy wąskolistnej (Lavandula angustifolia L.) w powszechnie dostępnym preparacie handlowym. Post Fitoter. 2017;18(2):113- 118. 44.
Sahin F, Gulluce M, Daferera D, Sokmen A, Polissiou M, Agar G, Ozer H. Biological activities of the essential oils and the methanol extract of Origanum vulgare ssp. vulgare in the Eastern Anatolia region of Turkey. Food Control 2004;15:549-57. 45.
Inouye S, Nishiyama Y, Hasumi KUY, Yamaguchi H, Abe S. The vapor activity of oregano, perilla, tea tree, lavender, clove, and geranium oils against a Trichophyton mentagrophytes in a closed box. J Infect Chemother. 2006;12(6):349-54. 46.
Leyva-López N, Gutiérrez-Grijalva EP, Vazquez-Olivo G, Heredia JB. Essential Oils of Oregano: Biological Activity beyond Their Antimicrobial Properties. Molecules. 2017;22(6):989. 47.
Kędzia A, Ziółkowska-Klinkosz M, Lassmann Ł, Kochańska B, Kusiak A, Gębska A, Wojtaszek- Słomińska A. Przeciwgrzybicze działanie olejku goździkowego. Post Fitoter. 2014;1:15-18.
|
POLSKI
